Will AkzoNobel and Axalta complete their merger before 31 December 2026?
deadline 2026-12-31
confidence medium
tier 2 evidence
33%Asturna estimate
Resolution criterion
Yes if AkzoNobel and/or Axalta announce, by press release or SEC filing, that the merger has been completed (closing has occurred) on or before 31 December 2026. An announcement of regulatory clearance, or of an expected closing date, without the completion itself does not count. No completion announced by that date resolves No.
Verified starting state
Merger agreement signed on 18 November 2025. The proxy statement filed with the SEC (Axalta DEFM14A, 2026) says the companies expect to complete the transaction in "late 2026 to early 2027"; the end date is 18 May 2027, extendable to 18 November 2027 in certain circumstances. Axalta and AkzoNobel shareholders approved the merger (August 2026 press reports). The sources read do not confirm that the required regulatory clearances (US antitrust under the HSR Act, the EU, and others) have been obtained.
What pushes it up
- Shareholder approvals have already been secured and the companies have formally submitted remedies to obtain EU antitrust clearance [tier 2].
- Preparations for closing are advancing, including announcing the unified post-merger brand 'Axanzo' [tier 2].
What pushes it down
- The official proxy filing (DEFM14A) explicitly targets completion between late 2026 and early 2027, leaving a strong possibility that closing occurs in Q1 2027 [tier 1].
- Antitrust regulatory clearances in major jurisdictions, including the EU and UK, remain pending as of mid-October 2026 with only ten weeks remaining in the year [tier 2].
What would move this number most
The speed with which European and UK competition authorities formally issue final approvals following the submission of remedies.
How this number is built
| Deadline | 2026-12-31 |
| Base rate | 40% |
| Best evidence | tier 2 · 4 article(s) used |
| Independent runs | 30 · 35 (spread 5 pts) |
| Confidence | medium |
| Evidence cap | not triggered |
| Last revised | 2026-10-18 09:10 |
| Model | gemini-3.6-flash |
Sources consulted
Probability history
2026-10-18 09:10 33% 26 article(s) on file · gemini-3.6-flash
- What pushes it up. Shareholder approvals have already been secured and the companies have formally submitted remedies to obtain EU antitrust clearance [tier 2].
- What pushes it up. Preparations for closing are advancing, including announcing the unified post-merger brand 'Axanzo' [tier 2].
- What pushes it down. The official proxy filing (DEFM14A) explicitly targets completion between late 2026 and early 2027, leaving a strong possibility that closing occurs in Q1 2027 [tier 1].
- What pushes it down. Antitrust regulatory clearances in major jurisdictions, including the EU and UK, remain pending as of mid-October 2026 with only ten weeks remaining in the year [tier 2].
- What would move this number most. The speed with which European and UK competition authorities formally issue final approvals following the submission of remedies.
2026-10-17 15:01 28% 24 article(s) on file · gemini-3.8-flash
- What pushes it up. Shareholder approvals are already secured as of August 2026 [tier 1].
- What pushes it up. Remedies have been submitted to the European Commission, and reports indicate the parties are poised to secure EU antitrust clearance [tier 2].
- What pushes it up. Integration steps are moving rapidly, including unveiling the post-merger company identity 'Axanzo' with meetings scheduled for late November [tier 2, tier 4].
- What pushes it down. The official proxy statement projected closing between 'late 2026 to early 2027' with a long-stop date in May 2027, making a 2027 closing explicitly contemplated [tier 1].
- What pushes it down. Key regulatory clearances (EU, US HSR, UK CMA) have not yet been granted, with remedies only offered in mid-October and a UK probe underway since mid-September [tier 1, tier 2].
- What pushes it down. With only 75 days until 31 December 2026, satisfying regulatory remedy commitments (e.g. divestiture processes) and closing conditions for a $25 billion merger makes a completion before year-end very tight [tier 1, tier 2].
- What would move this number most. The timing of final, unconditional clearance decisions from the European Commission and the UK CMA, and whether remedies require an upfront buyer prior to closing.
2026-10-16 12:03 34% 21 article(s) on file · gemini-flash-latest
- What pushes it up. Shareholder approval has already been secured by both AkzoNobel and Axalta [tier 1].
- What pushes it up. Reuters reports the companies are poised to secure EU antitrust clearance following remedy offers [tier 2, article 0], supported by trade reports of divestment proposals [tier 4, article 2].
- What pushes it up. Post-merger integration steps, such as establishing the new combined name Axanzo, are actively progressing [tier 4, article 3].
- What pushes it down. The official proxy statement projected closing between 'late 2026 to early 2027' with long-stop dates well into 2027, making a slip past December 31 very plausible within their stated plan [tier 1].
- What pushes it down. Only 2.5 months remain before the deadline, while the UK Competition and Markets Authority only recently initiated its probe in mid-September 2026 [tier 2, article 1].
- What pushes it down. US antitrust clearance and formal EU approval have not yet been granted [tier 1], and finalizing divestitures or remedies typically requires additional weeks before closing can legally occur.
- What would move this number most. Whether the UK CMA and EU regulators grant final clearance without requiring Phase 2 investigations or protracted remedy negotiations before mid-December 2026.
2026-10-15 16:44 45% 10 article(s) on file · openai/gpt-oss-120b (Groq)
- What pushes it up. EU antitrust approval appears likely according to Reuters report, removing a major hurdle [2]
- What pushes it down. No confirmed regulatory clearances yet; proxy expects completion late 2026 to early 2027, so could slip past the deadline [hand‑verified tier 1]
- What pushes it down. Tier‑4 name announcements provide no evidence of closing
- What would move this number most. Whether the EU, US and other antitrust authorities grant clearance before 31 Dec 2026